These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23018424)

  • 1. Intravitreal injections: is there benefit for a theatre setting?
    Abell RG; Kerr NM; Allen P; Vote BJ
    Br J Ophthalmol; 2012 Dec; 96(12):1474-8. PubMed ID: 23018424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting.
    Tabandeh H; Boscia F; Sborgia A; Ciracì L; Dayani P; Mariotti C; Furino C; Flynn HW
    Retina; 2014 Jan; 34(1):18-23. PubMed ID: 24362413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
    Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
    Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection.
    Artunay O; Yuzbasioglu E; Rasier R; Sengül A; Bahcecioglu H
    Eye (Lond); 2009 Dec; 23(12):2187-93. PubMed ID: 19218994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endophthalmitis after resident-performed intravitreal bevacizumab injection.
    Falavarjani KG; Aghamirsalim M; Modarres M; Hadavandkhani A; Hashemi M; Parvaresh MM; Naseripour M; Samiy N
    Can J Ophthalmol; 2015 Feb; 50(1):33-6. PubMed ID: 25677280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of acute endophthalmitis after intravitreal bevacizumab injection in a single clinical center.
    Falavarjani KG; Modarres M; Hashemi M; Parvaresh MM; Naseripour M; Zare-Moghaddam A; Nekoozadeh S
    Retina; 2013 May; 33(5):971-4. PubMed ID: 23400076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy.
    Lima LH; Zweifel SA; Engelbert M; Sorenson JA; Slakter JS; Cooney MJ; Klancnik JM; Yannuzzi LA; Freund KB
    Retina; 2009 Oct; 29(9):1213-7. PubMed ID: 19934815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endophthalmitis after intravitreal injection: the importance of viridans streptococci.
    Chen E; Lin MY; Cox J; Brown DM
    Retina; 2011 Sep; 31(8):1525-33. PubMed ID: 21878800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral simultaneous intravitreal injections in the office setting.
    Bakri SJ; Risco M; Edwards AO; Pulido JS
    Am J Ophthalmol; 2009 Jul; 148(1):66-9.e1. PubMed ID: 19403114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting.
    Hasler PW; Bloch SB; Villumsen J; Fuchs J; Lund-Andersen H; Larsen M
    Acta Ophthalmol; 2015 Mar; 93(2):122-5. PubMed ID: 25403735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection.
    Mason JO; White MF; Feist RM; Thomley ML; Albert MA; Persaud TO; Yunker JJ; Vail RS
    Retina; 2008 Apr; 28(4):564-7. PubMed ID: 18398358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
    Fintak DR; Shah GK; Blinder KJ; Regillo CD; Pollack J; Heier JS; Hollands H; Sharma S
    Retina; 2008; 28(10):1395-9. PubMed ID: 18827737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of sterile intraocular inflammatory responses after intravitreal bevacizumab injection.
    Chong DY; Anand R; Williams PD; Qureshi JA; Callanan DG
    Retina; 2010 Oct; 30(9):1432-40. PubMed ID: 20559156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.
    Moshfeghi AA
    Semin Ophthalmol; 2011 May; 26(3):139-48. PubMed ID: 21609227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab for exudative age-related macular degeneration in clinical practice.
    Jonas JB; Tao Y; Schlichtenbrede FC
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):467-70. PubMed ID: 21682590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal macular electroretinograms after intravitreal injections of bevacizumab for age-related macular degeneration.
    Iwata E; Ueno S; Ishikawa K; Ito Y; Uetani R; Piao CH; Kondo M; Terasaki H
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4185-90. PubMed ID: 22618591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents.
    Good TJ; Kimura AE; Mandava N; Kahook MY
    Br J Ophthalmol; 2011 Aug; 95(8):1111-4. PubMed ID: 20702430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.